EC Nonprescription Access In 40 California Pharmacies Expected By 2003
This article was originally published in The Tan Sheet
Executive Summary
A pilot program enabling pharmacists to dispense emergency contraceptives without a prescription in San Francisco Bay- and Los Angeles-area pharmacies should expand to 30 to 40 locations within three years, according to the nonprofit Public Health Institute.
You may also be interested in...
Plan B
Label comprehension study analysis expected by early September, after which actual use study will begin in preparation for switch NDA, Women's Capital Corp. says Aug. 1. Firm also will gather post-marketing surveillance data on nonprescription emergency contraceptive use in Europe and British Columbia along with data from U.S. pilot programs. A behavioral study on EC use underway by UC-San Francisco researchers, who began recruitment in July (1"The Tan Sheet" Jan 1, p. 12). Label comp study expected to end in late 2001, with switch application planned for early summer 2002
Plan B
Label comprehension study analysis expected by early September, after which actual use study will begin in preparation for switch NDA, Women's Capital Corp. says Aug. 1. Firm also will gather post-marketing surveillance data on nonprescription emergency contraceptive use in Europe and British Columbia along with data from U.S. pilot programs. A behavioral study on EC use underway by UC-San Francisco researchers, who began recruitment in July (1"The Tan Sheet" Jan 1, p. 12). Label comp study expected to end in late 2001, with switch application planned for early summer 2002
Plan B
Label comprehension study analysis expected by early September, after which actual use study will begin in preparation for switch NDA, Women's Capital Corp. says Aug. 1. Firm also will gather post-marketing surveillance data on nonprescription emergency contraceptive use in Europe and British Columbia along with data from U.S. pilot programs. A behavioral study on EC use underway by UC-San Francisco researchers, who began recruitment in July (1"The Tan Sheet" Jan 1, p. 12). Label comp study expected to end in late 2001, with switch application planned for early summer 2002